Welcome to Spring 2023—check out some of our new articles we've written since our last send.
If it does not display correctly, here to view it in your browser.
April 2023
Welcome back to the NantHealth Blog Digest, seventeenth edition. As we enter Q2 and spring of 2023, we've been busy writing new blog posts. Please check out some of our new articles we've written since our last send.
As a reminder, by subscribing to our NantHealth Blog you'll be the first to receive the latest industry insights and thought leadership perspectives from our team of experts. We hope you enjoy this digest and look forward to connecting with you for the balance of the year.
Practices and Medical Groups | 2 minute read | NantHeath, Inc.
Managing High Drug Costs a Top Priority in Cancer Care
If a recent LinkedIn poll is any indication, managing high drug costs associated with cancer care continues to be a major concern for payers and providers alike. When asked? — What do you think is the most important factor for enhancing oncology care today? — 35 percent of the respondents chose managing high drug costs.
Industry Event & Tradeshow | 3 minute read time | Gene Pinder, Marketing Manager
Inspector General Asks Health Plans to Stay Vigilant about Fraud, Waste, and Abuse
Health plans are used to risk. In fact, it’s part of their DNA. But if there is one risk health plan leaders would like to never have to deal with—the risk of fraud might rank high on their list.
NEW eBOOK: Emerging technology—What health plans need to know for 2023
Download the eBook to gain valuable insights into the emerging technologies that will shape the healthcare industry in the coming year. Discover what health plans need to know about the latest developments in healthcare technology and be at the forefront of this exciting transformation.
NantHealth | Eviti Connect | Case Study Library
Discover the Power of Eviti Through Real Case Studies that show Payer Savings
These case studies offer real-life examples of how Eviti Connect has helped leading payer organizations realize cost savings and reduced variability in care for oncology and autoimmune diseases care.